Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolio

Uber teams up with ScriptDrop to expand prescription delivery access in U.S.

Published 03/24/2021, 01:38 PM
Updated 03/24/2021, 02:00 PM
© Reuters. FILE PHOTO: A screen displays the company logo for Uber Technologies Inc in 2019
AMZN
-
UBER
-

(Reuters) - Uber Technologies (NYSE:UBER) Inc will work with prescription delivery services provider ScriptDrop to enable customers in 37 U.S. states to receive medication at their doorstep, the ride-hailing service said in a blog post. (https://ubr.to/3978Gz5)

Pharmacies signed up with ScriptDrop will be able to use Uber's delivery services, which could result in fewer events of customers going without their prescriptions due to COVID-19 related limitations, the post said on Wednesday.

The partnership news comes as big tech companies are increasingly pushing into the healthcare sector. Earlier this month, Amazon.com Inc (NASDAQ:AMZN) expanded its virtual healthcare services, after launching an online pharmacy last year.

Last August, Uber partnered with on-demand prescription delivery platform NimbleRx.

Uber will become the default application for select ScriptDrop pharmacies, depending on location and driver availability, the company said, adding that it plans to expand the services to more pharmacies in the coming weeks and months.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.